8PU-20392-72271
4 vaccinations
9 coded responses
36 check-ins
10 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 841 / UT
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: Good · Site: Pain · HeadacheFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-26
- 2020-12-28
- 2020-12-29
- 2021-01-05
- 2021-01-13
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Feeling hot — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Felt warm but did not have a feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities2 call case(s)
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Good · Site: PainFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-20
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2021-04-15
Survey response — 3 months, dose 2MedDRA: Headache, Oropharyngeal pain — Feeling: FairFree text: Sore throat & headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-15
-
2021-10-21
Dose 3 — Pfizer-BioNTech
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Heavy menstrual bleeding, Night sweats — Feeling: GoodFree text: Night sweats Increased menstrual bleedingMedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Dose 4 — Pfizer-BioNTech
-
2022-11-17
Survey response — day 0, dose 4MedDRA: Pregnancy — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-11-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-11-20
- 2022-11-21
- 2022-11-22
- 2022-11-23
-
2022-11-24
Survey response — day 7, dose 4MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-03
-
2022-12-08
Survey response — day 21, dose 4MedDRA: Headache, Oropharyngeal pain — Feeling: FairFree text: Headache & Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-12-16
-
2022-12-24
Health check-in — day 35, dose 4Feeling: Poor · Be unable to work or attend schoolFree text: DiarrheaAdult check-in · check-in free text available
-
2022-12-29
Survey response — day 42, dose 4MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have covidMedDRA releases: 2024-11 · check-in free text available
-
2022-12-29
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-30
Call successfulDoes not wish to fill out VAERS report
-
2022-12-30
Call successfulDoes not wish to fill out VAERS report
- 2023-02-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-11-17 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Dizziness
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Felt warm but did not have a fever
Systemic reaction (other): Sore throat
Release 7 — 3 months, dose 2
Symptoms: Sore throat & headaches
Release 10 — 12 months, dose 2
Symptoms: Night sweats Increased menstrual bleeding
Release 12 — day 0, dose 4
Systemic reaction (other): Pregnant
Release 12 — day 7, dose 4
Systemic reaction (other): Runny nose
Release 12 — day 21, dose 4
Symptoms: Headache & Sore throat
Release 12 — day 35, dose 4
Symptoms: Diarrhea
Release 12 — day 42, dose 4
Symptoms: I have covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pregnancy | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release